Suchergebnisse - "Parr, Maria Kristina"

PubPharm (149)

1

Whiter and Greener RP-HPLC Method for Simultaneous Determination of Dorzolamide, Brinzolamide, and Timolol Using Isopropanol as a Sustainable Organic Solvent in the Mobile Phase

enthalten in: Preprints.org | 2024

von El Deeb, S. | Abdelsamad, K. | Parr, M.

2

Biotransformation of anabolic androgenic steroids in human skin cells

enthalten in: The Journal of steroid biochemistry and molecular biology | 2024

von Liu, L. | Karim, Z. | Schlörer, N. | +4

3

Quinoa as phytopharmaceutical? Urinary elimination of ecdysterone after consumption of quinoa alone and in combination with spinach

enthalten in: Archiv der Pharmazie | 2024

von Isenmann, E. | Yuliandra, T. | Touvleliou, K. | +5

4

Routine application of SFC-MS in doping control : Analysis of 3 × 1000 urine samples using three different SFC-MS instruments

enthalten in: Drug testing and analysis | 2024

von Gavrilović, I. | Wüst, B. | Danaceau, J. | +5

5

ICH Q14-inspired novel approach to establish an SFC-based purity method for carbamazepine

enthalten in: Drug testing and analysis | 2024

von Schmidt, A. | Stanic, M. | Parr, M.

6

Sample Preparation Techniques for Growth-Promoting Agents in Various Mammalian Specimen Preceding MS-Analytics

enthalten in: Molecules (Basel, Switzerland) | 2024

von Klöppner, L. | Harps, L. | Parr, M.

7

SFC-MS/MS for orthogonal separation of hydroxylated 17α-methyltestosterone isomers

enthalten in: Drug testing and analysis | 2023

von Bredendiek, F. | Parr, M.

8

Novel approach to supercritical fluid chromatography-mass spectrometry analysis of metal ions using EDTA complexation

enthalten in: Analytica chimica acta | 2023

von Plachká, K. | Bredendiek, F. | Nováková, L. | +1

9

Glucuronidation Pathways of 5- and 7-Hydroxypropranolol : Determination of Glucuronide Structures and Enzyme Selectivity

enthalten in: Molecules (Basel, Switzerland) | 2023

von Yang, F. | Wenzel, M. | Bureik, M. | +1

10

Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximab

enthalten in: Journal of pharmaceutical and biomedical analysis | 2023

von Dyck, Y. | Rehm, D. | Winkler, K. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]